If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGb Group Regulatory News (GBG)

Share Price Information for Gb Group (GBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 319.00
Bid: 318.60
Ask: 319.00
Change: 5.80 (1.85%)
Spread: 0.40 (0.126%)
Open: 320.00
High: 320.20
Low: 309.60
Prev. Close: 313.20
GBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Succession Plan for CFO

28 Jan 2021 07:00

RNS Number : 1266N
GB Group PLC
28 January 2021
 

 

 

Embargoed until 7.00 a.m.

28 January 2021

 

GB GROUP PLC

("GBG", the "Group" or the "Company")

 

Succession Plan for CFO

 

GBG is pleased to announce the appointment of David Mathew Ward to its Board as its new CFO, replacing Dave John Wilson, who is stepping down from the Board and retiring as CFO and COO after 12 years. It is anticipated that David Ward will join GBG on 17th May 2021, with Dave Wilson leaving at the end of June thereby providing sufficient time to complete an orderly handover.

 

The Board would like to thank Dave Wilson for his significant contribution to the growth and success of GBG during his time as CFO. During Dave's tenure at GBG the Group has evolved from a small UK operation to a truly international business with over 65% of revenue generated outside the UK (as per 6 months ended 30 Sept 2020), customers in over 70 countries and team members in 16 countries. Over the same period, GBG has increased its market capitalisation more than 100x, from c. £14.2m in April 2009 to c. £1.7bn today.

 

David Ward is a highly experienced, successful and well-regarded business leader who has spent the last 10 years with AVEVA Group plc ('AVEVA'), the FTSE 100 global software group. Prior to the merger with the software business of Schneider Electric, David was CFO, subsequently becoming Finance Director & Company Secretary of the enlarged group. During his time with AVEVA, the company has scaled financially and geographically, with David leading a number of M&A projects, as well as restructuring finance, business operations and processes. David is an economics graduate and a qualified chartered accountant, having spent his early career with Ernst & Young. The combination of his experience, drive and culture makes him an ideal fit for GBG's next stages of growth.

 

David Rasche, Chairman of GBG, said:

"I would like to thank Dave Wilson for his 12 years with GBG, during which time he has been a key member of the Board helping to transform the business and deliver outstanding shareholder returns. In terms of product portfolio, customer focus and success, international growth and delivering shareholder value, GB Group has come a long way from the business Dave joined. Dave is highly respected by our investor community and by all his colleagues in the business.

 

"I know that Dave will remain a good friend of the business and we wish him well for his retirement.

 

"After a thorough and rigorous search process initiated with Odgers Berndtson, the Board is delighted that David Ward has agreed to join GBG as its CFO. David has been key to impressive growth and financial governance improvements at AVEVA over his tenure and I am confident that his experience will be an asset to GBG as we continue our own growth story".

 

Chris Clark, Chief Executive of GBG, said;

"I'd like to thank Dave Wilson personally for his focus and support since I joined GBG four years ago. It has been a pleasure working with him. As we continue our ambitious growth journey I am delighted that David Ward has decided to join me and the GBG Board. During the search it became clear that David has really strong experience of leading a business along an international growth trajectory, similar to what we have ahead. We also believe that his style will be a great fit with the culture of GBG, something that we are very careful to nurture and evolve."

 

Dave Wilson, CFO & COO of GBG, said;

"It has been a privilege to work with past and present team members, who are the essence of such a great business. My 12 years at GBG has been fun and rewarding, which has given me many proud moments. It is the right time for me to move to non-executive roles, and I thank the Board, our team, advisors and the investment community for their support over the years"

 

Commenting on his new role, David Ward added:

"The fundamental strengths of GBG's products and the opportunities which exist for the business within its markets, made this opportunity instantly compelling. Having met various members of the Board and Executive, it became clear that the culture and focus of the business are important strengths. It is rare to find a business with the market opportunity, strategy and ambition to deliver, combined with the culture to succeed. I will be joining GBG at a very exciting chapter in its growth journey and look forward to leveraging my experience of international expansion and finance operations to enable further success building on Dave's impressive legacy."

 

As part of David Ward's remuneration, upon taking up his appointment ('Date of Grant') he will receive an option over 150,000 Ordinary Shares in the capital of the Company as compensation to match the earnings and incentives forfeited on leaving his previous employer (the 'Compensatory Options'). The Compensatory Options will be issued at an exercise price of 2.5 pence per Ordinary Share and will vest in equal tranches on the first, second and third anniversary from the Date of Grant provided he still holds the position of CFO of GBG on the respective dates. In addition, vesting of the second and third tranches will also be subject to achievement of EPS and TSR performance targets in line with the Group's objectives and beyond. The Compensatory Options are valid for a period of 12 months from the vesting date.

 

In accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies, David Mathew Ward (44) holds or has held in the past 5 years the following directorships and partnerships:

 

Current:

8over8 Limited (in liquidation)

AVEVA de Mexico S. de R.L. de C.V.

AVEVA Limited

AVEVA AB

AVEVA AB branch in Finland

AVEVA Consulting Limited

AVEVA Finance Limited

AVEVA Financing Limited

AVEVA GmbH

AVEVA GmbH branch in Austria

AVEVA KK

AVEVA Korea Limited

AVEVA PTE Limited

AVEVA Solutions Limited

AVEVA Software and Services SA de CV

AVEVA Yazilim Ve Hizmetleri A.S.

AVEVA Chile SPA

AVEVA Denmark A/S

AVEVA East Asia Limited

AVEVA Engineering It Limited

AVEVA Group Plc

AVEVA Information Technology India Private Limited

AVEVA Managed Services Limited

AVEVA (The Netherlands) BV

AVEVA SA

AVEVA SA branch in Italy

AVEVA SA branch in Spain

AVEVA (Shanghai) Consultancy Co Limited

AVEVA Solutions (Shanghai) Co., Ltd

AVEVA UK 1 Limited

AVEVA GmbH Sp. z o.o. Oddzial w Polsce

Cadcentre Engineering It Limited

Cadcentre Limited

Cadcentre Property Limited

Fabtrol Systems, Uk Limited (in liquidation)

LFM Software Limited

Schneider Electric Software GB Denmark branch, filial af Schneider Electric Software GB Ltd., England

Schneider Electric Software Netherlands B.V.

Schneider Electric Software Spain S.L.

Schneider Electric Software France SAS

Schneider Electric Software GB Limited

Schneider Electric Software RU (in liquidation)

Schneider Electric Software Holdings Netherlands B.V.

Schneider Electric Software Italia S.p.A.

Tribon Solutions (Uk) Limited

 

Past:

AVEVA Group PLC where he was CFO & Main Board Director from July 2016 to February 2018. A Board re-structure took place as a result of the AVEVA merger with Schneider Electric SE.

 

Mr Ward holds no shares in the Company.

 

There is no further information required to be disclosed in respect of the above appointment pursuant to Schedule 2 (g) of the AIM Rules for Companies.

 

For further information, please contact:

 

GBG

Chris Clark, CEO & Dave Wilson, CFO & COO

 

+44 (0) 1244 657333

Peel Hunt LLP (Nominated Adviser and Broker)

Edward Knight, Paul Gillam & Nick Prowting

 

+44 (0) 20 7418 8900

 

Tulchan Communications LLP

James Macey White, Matt Low & Tom Blundell

 

+44 (0) 20 7353 4200

GBG@tulchangroup.com

 

Website

www.gbgplc.com/investors

 

About GBG

GBG offers a range of solutions that help organisations quickly validate and verify the identity and location of their customers.

 

Our market-leading technology, data and expertise help our customers improve digital access, deliver a seamless experience and establish trust, so that they can transact quickly, safely and securely with their customers online. 

 

Headquartered in the UK and with over 1,000 team members across 16 countries, we work with 20,000 customers in over 70 countries. Some of the world's best-known businesses rely on GBG to provide digital services and keep the economy moving, from US e-commerce giants to Asia's biggest banks and European household brands.

 

To find out more about how we help our customers establish trust with their customers, visit www.gbgplc.com and follow us on LinkedIn and Twitter @gbgplc.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAVDLFLFFLEBBF
Date   Source Headline
30th Apr 20243:00 pmRNSTotal Voting Rights
29th Apr 20247:00 amRNSDirectorate Change
26th Apr 20242:33 pmRNSHolding(s) in Company
23rd Apr 20247:00 amRNSFY24 trading update
28th Mar 202412:47 pmRNSTotal Voting Rights
29th Feb 20243:44 pmRNSTotal Voting Rights
31st Jan 20244:59 pmRNSDirector/PDMR Shareholding
31st Jan 20241:00 pmRNSTotal Voting Rights
30th Jan 20247:00 amRNSDirectorate change and in-line trading update
26th Jan 20248:30 amRNSHolding(s) in Company
19th Jan 202410:01 amRNSBlock listing Interim Review
29th Dec 202311:54 amRNSTotal Voting Rights
19th Dec 20238:50 amRNSHolding(s) in Company
4th Dec 20231:49 pmRNSDirector/PDMR Shareholding
30th Nov 20232:12 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSHalf-year Report
8th Nov 20237:00 amRNSDirectorate Change
31st Oct 20233:15 pmRNSTotal Voting Rights
23rd Oct 20232:12 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSHalf-year trading update
29th Sep 20237:00 amRNSTotal Voting Rights
31st Aug 20232:03 pmRNSTotal Voting Rights - Correction
31st Aug 20237:00 amRNSTotal Voting Rights
10th Aug 20234:47 pmRNSPDMR shareholding, Issue of Ordinary Shares & TVR
31st Jul 20237:00 amRNSTotal Voting Rights
20th Jul 202312:26 pmRNSResult of AGM
20th Jul 20237:00 amRNSAGM Statement
19th Jul 20237:00 amRNSBlock listing Interim Review
14th Jul 20232:13 pmRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSTotal Voting Rights
26th Jun 20235:24 pmRNSPosting of Annual Report and Notice of AGM
15th Jun 20237:00 amRNSFinal Results
31st May 20237:00 amRNSTotal Voting Rights
2nd May 20232:01 pmRNSTotal Voting Rights
24th Apr 20237:00 amRNSDirector Dealing
20th Apr 20237:00 amRNSPre-close trading update
6th Apr 20233:01 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202312:59 pmRNSHolding(s) in Company
24th Mar 20238:58 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSDirector Retirement
28th Feb 20237:00 amRNSTotal Voting Rights
22nd Feb 20237:00 amRNSDirector Dealing
21st Feb 20237:00 amRNSTrading update
7th Feb 20237:00 amRNSBlock listing Interim Review
31st Jan 20237:00 amRNSTotal Voting Rights
24th Jan 20233:30 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSCapital Markets Event
29th Nov 20227:00 amRNSHalf-year Report
11th Nov 20228:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.